InfuSystem CEO receives new RSU and option grants

InfuSystem Holdings President and CEO Carrie Lachance reported new equity awards and updated holdings.

Rhea-AI Filing Summary

InfuSystem Holdings President and CEO Carrie Lachance reported new equity awards and updated holdings. She received a grant of 29,816 restricted stock units, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning on May 12, 2027. She also received a stock option covering 62,117 shares of common stock at an exercise price of $8.37 per share, expiring on May 12, 2036, vesting in four equal annual installments starting May 12, 2027. Following these awards, she directly holds 238,123 shares of InfuSystem common stock. These actions reflect compensation-related grants rather than open-market purchases or sales.

Insider Trade Summary

Grant/Award: 91,933 shares

Grant/Award 3 txns

Insider Lachance Carrie

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	62,117	$0.00	$0.00
Grant/Award	Restricted Stock Units	29,816	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 62,117 contracts (Direct); Restricted Stock Units — 29,816 contracts (Direct); Common Stock — 238,123 shares (Direct)

Footnotes (3)

1. F1. The option, representing the right to purchase a total of 62,117 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027.
2. F2. Restricted stock units convert into common stock on a one-for-one basis.
3. F3. These restricted stock units vest in three equal annual installments beginning on May 12, 2027.

Key Figures

RSU grant size: 29,816 units Option grant size: 62,117 shares Option exercise price: $8.37/share +4 more

7 metrics

RSU grant size 29,816 units Restricted stock units granted on May 12, 2026

Option grant size 62,117 shares Stock option (right to buy) granted on May 12, 2026

Option exercise price $8.37/share Conversion or exercise price for stock option

Option expiration May 12, 2036 Expiration date of stock option grant

Shares held after transactions 238,123 shares Common stock directly held following reported transactions

RSU vesting start May 12, 2027 RSUs vest in three equal annual installments from this date

Option vesting start May 12, 2027 Options vest in four equal annual installments from this date

Key Terms

Restricted stock units, Stock Option (right to buy), vests in four equal annual installments, convert into common stock on a one-for-one basis, +1 more

5 terms

Restricted stock units financial

"The option, representing the right to purchase a total of 62,117 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Option (right to buy) financial

"The option, representing the right to purchase a total of 62,117 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027."

vests in four equal annual installments financial

"The option, representing the right to purchase a total of 62,117 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027."

convert into common stock on a one-for-one basis financial

"Restricted stock units convert into common stock on a one-for-one basis."

vest in three equal annual installments financial

"These restricted stock units vest in three equal annual installments beginning on May 12, 2027."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did InfuSystem (INFU) CEO Carrie Lachance receive?

Carrie Lachance received 29,816 restricted stock units and a stock option for 62,117 shares. The RSUs convert one-for-one into common stock, and both awards vest over multiple years starting in 2027 as part of her compensation.

How do Carrie Lachance’s new InfuSystem (INFU) stock options work?

She received a stock option for 62,117 InfuSystem common shares at an exercise price of $8.37 per share. The option expires on May 12, 2036 and vests in four equal annual installments beginning May 12, 2027.

When do Carrie Lachance’s new InfuSystem (INFU) RSUs vest?

The 29,816 restricted stock units vest in three equal annual installments starting May 12, 2027. Once vested, each RSU converts into one share of InfuSystem common stock, increasing her direct equity exposure over time.

Did InfuSystem (INFU) CEO Carrie Lachance buy or sell shares in this Form 4?

The Form 4 shows compensation-related grants, not open-market trades. It reports new restricted stock units and stock options awarded to her, plus an updated total of 238,123 directly held common shares after these awards.

How many InfuSystem (INFU) shares does Carrie Lachance hold after these awards?

After the reported transactions, she directly holds 238,123 shares of InfuSystem common stock. This figure excludes the 29,816 restricted stock units and 62,117 stock options, which may add to her ownership as they vest and are exercised.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 06:29 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lachance Carrie

(Last) (First) (Middle)

C/O INFUSYSTEM HOLDINGS, INC.

3851 WEST HAMLIN ROAD

(Street)

ROCHESTER HILLS MICHIGAN 48309

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InfuSystem Holdings, Inc [ INFU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								238,123	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.37	05/12/2026		A		62,117		(1)	05/12/2036	Common Stock	62,117	$0	62,117	D
Restricted Stock Units	(2)	05/12/2026		A		29,816		(3)	05/12/2029	Common Stock	29,816	$0	29,816	D

Explanation of Responses:

1. The option, representing the right to purchase a total of 62,117 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027.

2. Restricted stock units convert into common stock on a one-for-one basis.

3. These restricted stock units vest in three equal annual installments beginning on May 12, 2027.

Remarks:

	/s/ Kevin Whitman, Attorney-in-Fact for Carrie Lachance	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)